Arch Biopartners Receives Health Canada Approval to Conduct
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it...
United States Arch Biopartners Inc Health Canada Drug Administration Turkish Ministry Of Health Biopartners Inc
Source: globenewswire.com